Tamoxifen Citrate



Indications and Reactions:

Role Indications Reactions
Primary
Breast Cancer 70.9%
Product Used For Unknown Indication 5.4%
Drug Use For Unknown Indication 2.9%
Breast Cancer Female 2.8%
Breast Cancer In Situ 2.7%
Breast Cancer Metastatic 2.7%
Breast Cancer Stage I 1.4%
Breast Cancer Stage Ii 1.4%
Hypertension 1.3%
Prophylaxis 1.2%
Diabetes Mellitus 1.2%
Blood Pressure Increased 0.8%
Breast Cancer Recurrent 0.8%
Depression 0.8%
Hypothyroidism 0.8%
Osteoporosis 0.6%
Pain 0.6%
Anxiety 0.5%
Blood Cholesterol Increased 0.5%
Epilepsy 0.5%
Thrombosis 10.2%
Vaginal Haemorrhage 10.2%
Breast Cancer Recurrent 6.4%
Uterine Polyp 6.4%
Weight Increased 6.4%
Pulmonary Embolism 6.1%
Deafness 5.1%
Uterine Cancer 5.1%
Cerebrovascular Accident 4.8%
Visual Acuity Reduced 4.8%
Uterine Leiomyoma 4.5%
Deep Vein Thrombosis 3.8%
Disease Progression 3.8%
Endometrial Cancer 3.8%
Maculopathy 3.8%
Ovarian Cancer 3.5%
Weight Decreased 3.5%
Disease Recurrence 2.6%
Sinus Bradycardia 2.6%
Visual Disturbance 2.6%
Secondary
Breast Cancer 59.4%
Prophylaxis 6.1%
Breast Cancer Metastatic 4.2%
Drug Use For Unknown Indication 4.1%
Hypertension 3.9%
Product Used For Unknown Indication 3.5%
Premedication 2.4%
Malignant Melanoma Stage Iv 2.3%
Metastases To Bone 2.0%
Accidental Exposure 1.4%
Breast Cancer Female 1.3%
Depression 1.3%
Neoplasm 1.3%
Menopause 1.1%
Breast Cancer Stage Ii 1.1%
Pain 1.0%
Ill-defined Disorder 1.0%
Osteoporosis 0.9%
Chemotherapy 0.8%
Hormone Therapy 0.8%
Uterine Polyp 8.5%
Pyrexia 7.5%
Weight Increased 7.5%
Weight Decreased 7.0%
Vaginal Haemorrhage 6.6%
Hepatic Failure 6.1%
Hypothyroidism 5.6%
Acute Myeloid Leukaemia 5.2%
Pulmonary Embolism 5.2%
Osteonecrosis 4.7%
Aplastic Anaemia 4.2%
Uterine Leiomyoma 4.2%
Vitreous Floaters 4.2%
Breast Cancer 3.8%
Arthralgia 3.3%
Depression 3.3%
Interstitial Lung Disease 3.3%
Neoplasm Malignant 3.3%
Osteonecrosis Of Jaw 3.3%
Pulmonary Hypoplasia 3.3%
Concomitant
Breast Cancer 31.4%
Metastases To Bone 10.0%
Breast Cancer Metastatic 9.0%
Drug Use For Unknown Indication 6.8%
Product Used For Unknown Indication 6.4%
Depression 5.0%
Pain 4.8%
Osteoporosis 4.7%
Hypertension 3.9%
Prophylaxis 2.9%
Neoplasm Malignant 2.1%
Menopause 2.1%
Anxiety 2.0%
Osteopenia 1.4%
Rheumatoid Arthritis 1.4%
Chemotherapy 1.3%
Arthritis 1.3%
Insomnia 1.2%
Anaemia 1.1%
Diabetes Mellitus 1.1%
Weight Decreased 16.0%
Vomiting 13.3%
Tooth Extraction 9.3%
Weight Increased 7.9%
Osteonecrosis 6.3%
Breast Cancer 4.1%
Urinary Tract Infection 4.0%
Toothache 3.9%
Viral Infection 3.9%
Wound Drainage 3.8%
Wheezing 3.3%
Pain 3.2%
Wound Dehiscence 3.1%
Pain In Extremity 2.6%
Walking Aid User 2.6%
White Blood Cell Count Decreased 2.6%
X-ray Abnormal 2.6%
Hypertension 2.5%
Nausea 2.5%
Osteonecrosis Of Jaw 2.5%
Interacting
Breast Cancer 45.8%
Drug Use For Unknown Indication 25.3%
Breast Cancer Metastatic 4.8%
Depression 4.8%
Metastasis 3.6%
Breast Disorder 2.4%
Deep Vein Thrombosis 2.4%
Prophylactic Chemotherapy 2.4%
Anxiolytic Therapy 1.2%
Cancer Hormonal Therapy 1.2%
Dilatation Ventricular 1.2%
Epilepsy 1.2%
Hypokinesia 1.2%
Insomnia 1.2%
Mental Disorder 1.2%
Drug Interaction 26.9%
Weight Decreased 11.5%
Breast Cancer 3.8%
Drug Hypersensitivity 3.8%
Drug Level Decreased 3.8%
Hypertension 3.8%
International Normalised Ratio Increased 3.8%
Labelled Drug-drug Interaction Medication Error 3.8%
Major Depression 3.8%
Non-cardiac Chest Pain 3.8%
Osteonecrosis 3.8%
Osteoporosis 3.8%
Sinus Bradycardia 3.8%
Sleep Disorder 3.8%
Suicide Attempt 3.8%
Uterine Disorder 3.8%
Venous Thrombosis Limb 3.8%
Vomiting 3.8%